The United States Food and Drug Administration (USFDA) has issued a Warning Letter to Palamur Biosciences Private Limited, a preclinical contract research laboratory located ...
Caliway to Present First Preclinical Data on CBL-514 for GLP-1 Weight Rebound Management at BIO 2025
NEW TAIPEI CITY, June 10, 2025 /PRNewswire/ -- Caliway Biopharmaceuticals (TWSE: 6919) announced today its participation in the 2025 BIO International Convention, to be held from June 16 to 19 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results